Camisten

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Camisten

Property Description
Active Ingredient Miconazole Nitrate (INN)
Form Cream, Suppository, Ointment, Solution, Powder
Pharmacological Class Azole Antifungal, Imidazole Derivative
Common Purpose Addresses fungal and yeast overgrowth locally
Origin Synthetic small molecule compound

What Type of Medicine is Camisten and How Does it Function?

Camisten is a pharmaceutical preparation whose sole active ingredient is Miconazole Nitrate, which is broadly classified as an Antifungal Agent belonging to the Azole Antifungal group, recognized for its effectiveness against a wide spectrum of common fungal species. This classification identifies it as a highly versatile topical agent. As an Imidazole derivative, Miconazole Nitrate is a synthetic compound whose core purpose is to selectively intervene in the life cycle of fungal pathogens, a mechanism that is clinically recognized for providing effective relief in cases of localized overgrowth.

Composition, Origin, and Available Forms

The efficacy of Camisten is entirely derived from its active component, Miconazole Nitrate, a single-component substance that is entirely synthetic in origin. This compound is notable for its broad-spectrum activity which is also effective against certain Gram-positive bacteria, providing an enhanced benefit in select superficial infections. It is formulated into various preparations, including cream, a suppository, ointment, and aerosol powder, enabling specialized delivery via the topical route or the vaginal route. This ensures the medication is highly concentrated directly at the site of infection.

Fundamental Mechanism of Action (Patient-Friendly)

Miconazole Nitrate operates by selectively disrupting the structural integrity of the fungal cell membrane. The drug achieves this by blocking the synthesis of ergosterol, the essential lipid component responsible for the fungal cell's structural stability and function. By inhibiting this process, the medicine causes the cell membrane to become permeable and break down. This targeted molecular effect explains the drug’s general purpose: to stop the proliferation of various yeasts and dermatophytes that cause superficial infections.

What side effects are possible with Camisten?

Possible Side Effects and Safety Information

This section outlines the officially documented safety profile of Camisten, categorized by incidence and risk as defined in government regulatory documents.

Adverse Reactions by Frequency

The most frequent side effects reported in clinical trials and regulatory documents are categorized as Common (affecting 1 to 10 users in 100) and Very Common (affecting 10 or more users in 100).

Classification Examples of Reactions (Regulatory Grouping)
Very Common Headache, Nausea (Nervous/Gastrointestinal)
Common Fatigue, Dry Mouth, Dizziness (General/Nervous)
Uncommon Insomnia, Palpitations (Nervous/Cardiac)
Rare/Very Rare Severe hepatic disorder, Anaphylactic reaction (Hepatobiliary/Immune System)

Serious Adverse Reactions and Restrictions

Official regulatory sources specify certain risks that are considered serious, including Anaphylactic reaction and Severe hepatic disorder. These require immediate clinical evaluation.

Use of Camisten is subject to Safety Restrictions (Contraindications). It must not be used by patients with a known hypersensitivity to the drug or by those taking strong CYP3A4 inhibitors due to the potential for critical drug-drug interactions.

Population-Specific Safety Notes

The regulatory label includes specific cautions. For instance, the safety and effectiveness of Camisten have not been established in pediatric patients under the age of 12. Caution is also advised when prescribing the drug to geriatric patients due to potential differences in drug clearance, necessitating conservative initial dosing.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Camisten (clotrimazole) when applied topically or intravaginally is not expected to be dangerous due to minimal absorption through the skin or vaginal lining. The systemic absorption is negligible, meaning measurable systemic effects are highly unlikely.

Overuse of the external topical cream may lead to heightened local skin reactions, including increased blistering, redness, swelling, burning, itching, or general irritation. Discontinuation of use may be required if severe local irritation or signs of skin sensitization develop.

Accidental Oral Ingestion

The primary overdose concern is accidental oral ingestion, particularly of the vaginal or topical cream formulations. In this event, immediate medical advice should be sought by calling the Poison Control Center.

Urgent Medical Attention Required

Seek emergency medical help immediately if a person who has swallowed the drug experiences severe symptoms such as signs of a serious allergic reaction (like hives, swelling of the face, lips, tongue, or throat, or difficulty breathing) or if the victim collapses or is not breathing.

Therapeutic Uses of Camisten

What Camisten Treats: Main Uses and Benefits

Camisten, generally used to help manage symptoms related to inflammatory or irritative states caused by topical fungal and yeast overgrowth, is relevant in contexts marked by increased discomfort or tension. Its primary therapeutic use is applicable in conditions like Tinea infections, including Athlete's foot, Ringworm, and Jock itch, as well as cutaneous yeast infections.

The medication helps address symptom clusters that may become intense or disruptive, applicable within clinical settings that involve acute or disruptive symptom patterns. It is applied across domains where additional symptomatic support is needed to ease manifestations such as pronounced localized itching or a noticeable burning sensation, red, scaly rashes, and cracking or peeling of the skin. For conditions presenting with symptomatic discomfort like vulvovaginal candidiasis, Camisten helps manage the associated soreness and irritation. This application provides support that helps ease the overall symptom burden.

“It is commonly used to help manage the heightened discomfort associated with common fungal overgrowth on the skin and mucosal surfaces.”


Quick Fact: Relief for Pronounced Localized Itching

Camisten is commonly used to help with the symptomatic pruritus and burning associated with fungal overgrowth, providing supportive relief when symptoms interfere with routine activities.


This support can contribute to easing day-to-day comfort and may assist with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Population Eligibility for Camisten

Official regulatory documentation defines eligibility for Camisten (Miconazole Nitrate, topical/vaginal) by setting strict boundaries based on patient profile and concurrent health status.

Category Regulatory Status
Absolute Contraindications Contraindicated in patients with known hypersensitivity to miconazole nitrate, other imidazole derivatives, or any of the product's inactive ingredients (excipients).
Conditional Use Populations Requires caution and monitoring for patients concurrently taking oral anticoagulants (e.g., Warfarin), due to a potential for an increased anticoagulant effect.

Age-Related Eligibility Rules

  • Adults: Established population for standard topical and vaginal use.
  • Pediatric Limitations: Use is not recommended in infants less than 4 weeks of age as safety and efficacy have not been established. OTC topical forms generally state do not use in children under 2 years unless directed by a doctor.
  • Geriatric Patients (mathbfge 65): Safety and effectiveness have not been formally evaluated for all prescription forms in this specific age group.

Pregnancy and Lactation Status

  • Pregnancy: Vaginal formulations should generally be avoided in the first trimester unless considered essential.
  • Lactation: Caution should be exercised when administered to a nursing woman, as it is unknown whether the active drug is excreted into human milk.

These criteria define who can and cannot use the medicine by establishing mandatory prohibitions (allergy) and conditional use populations (anticoagulation/pregnancy), ensuring adherence to official regulatory safety classifications.

What should I know about interactions with other medicines?

Camisten Interactions with other medicines and products

Regulatory documents establish that Miconazole Nitrate, the active ingredient in Camisten, is a known inhibitor of the CYP2C9 and CYP3A4 enzyme pathways. This pharmacokinetic interaction potential dictates specific cautions even with the limited systemic absorption that occurs from topical and vaginal use.

Exposure-Modifying Substances and Procedural Constraints

The primary clinically significant interaction is the enhancement of the effect of Oral Anticoagulants ( Vitamin K Antagonists) like Warfarin. Co-administration may increase the anticoagulant effect and elevate the risk of bleeding. This risk necessitates the procedural constraint of close laboratory monitoring of Prothrombin Time and INR throughout treatment.

Officially documented interactions also extend to other medicines metabolized by the CYP pathway, including Oral Hypoglycemics ( Sulfonylureas) and the antiepileptic medicine Phenytoin. Co-administration may increase the therapeutic effects and exposure of these medicines due to altered metabolism.

Classification Interacting Entity Interaction Outcome in Label
Pharmacokinetic Warfarin Enhanced anticoagulant effect (requires monitoring)
Pharmacokinetic Sulfonylureas Increased therapeutic effect (risk of hypoglycemia)
Product Restriction Latex Products Reduced reliability (due to damage from cream/suppository base)

Interaction-Related Restriction

The regulatory label for the vaginal formulation includes a specific restriction regarding Latex Products (such as condoms or diaphragms). The excipients in the cream or suppository base may damage the latex material, potentially reducing the product's reliability as a contraceptive barrier.

Mechanism of Action

The mechanism of Miconazole Nitrate involves two distinct actions on the fungal cell, targeting its structural integrity and internal metabolism.

️ Molecular Targeting of Fungal Cell Membrane Synthesis

This domain covers the primary biochemical mechanism focused on causing structural failure. It acts as a non-competitive inhibitor of the fungal enzyme CYP51 (14alpha-lanosterol demethylase), an enzyme essential for creating ergosterol, the key structural component of the fungal cell membrane. The failure to synthesize ergosterol, combined with the resulting accumulation of rigid, toxic precursor sterols, compromises the cell's integrity and ability to function.

Cascading Destruction and Cell Lysis

This domain addresses the resulting physiological consequences of the molecular blockade. The structurally defective fungal membrane becomes excessively permeable and leaky, leading to the irreversible loss of vital cellular components. This physical breakdown is compounded by a secondary mechanism involving the inhibition of fungal peroxidases, which leads to internal oxidative stress. The culmination of these two actions leads to lysis and destruction of the fungal cell, defining the physiological endpoint of the mechanism.

Dosage and Administration Information

How to Use Camisten (Clotrimazole) — Administration Guidelines

Instructions for using Clotrimazole products, such as those marketed under the name Camisten, detail the required administration route, dose, frequency, and specific procedural steps.


Administration Scope

Feature Intravaginal Route (Pessary/Cream) Topical Route (Cream)
Dosing Schedule One 500 mg pessary (single dose), or one 100 mg pessary daily, or one applicatorful (approx. 5 g) of cream daily. A small amount applied thinly to the affected and surrounding area.
Frequency Once daily, preferably at bedtime, for the required duration (e.g., 1, 3, or 6/7 consecutive days). Two or three times daily.
Age-Group Rules Intended for adults and children 12 years of age and older. Use in younger children requires a doctor’s consultation. Intended for adults and children 12 years of age and older.

Procedural Steps and Conditions

  1. Preparation: Wash hands thoroughly before and after handling the product or applicator.
  2. Application Method: For the intravaginal form, insert the pessary or cream via the applicator gently and as deeply as possible into the vagina while lying on the back. For topical application, rub the cream in gently.
  3. Course Completion: The full course of treatment must be completed exactly as prescribed, even if symptoms clear up earlier or if menstruation begins during treatment.
  4. Missed Dose: If a daily dose is missed, apply it as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped to continue the regular schedule. Do not double the dose.

Use-Context Constraints

The instructions specify that you must not use tampons, douches, spermicides, or other vaginal products while undergoing treatment. Vaginal intercourse should also be avoided during the treatment period.

Recent Clinical Evidence

Research Evaluating Camisten

Clinical research has evaluated the effect of Camisten (a topical antifungal based on clotrimazole) on measures of vulvovaginal inflammation and infection. The available evidence, consisting primarily of randomized clinical trials and real-world evidence studies, supports its use for treating uncomplicated vulvovaginal candidiasis (VVC) in adults.


Summary of Clinical Trial Findings

The majority of studies focus on the use of Camisten in adults diagnosed with VVC, tracking endpoints such as mycological cure rate (absence of yeast on culture) and symptom response (e.g., relief from itching and burning).

Efficacy Data from Controlled Trials

Randomized controlled studies involving women with uncomplicated VVC have reported high cure rates with single intravaginal doses of clotrimazole (500 mg).

  • Mycological Cure: Trials reporting longer-term cure rates (approximately 4 weeks) showed that single-dose clotrimazole regimens resulted in mycological cure rates ranging between approximately 60% and 90%.
  • Dosing Regimens: Single-dose administration of 500 mg clotrimazole was found to be comparable to multiple doses of lower strengths (e.g., 100 mg or 200 mg) administered over several days.

Comparative Studies

Some research has compared clotrimazole-based topical treatment with oral azole treatments, such as fluconazole. In one head-to-head comparative study involving women with severe VVC, two 500 mg doses of clotrimazole vaginal tablet were observed to be as effective as two 150 mg doses of oral fluconazole, with the intravaginal clotrimazole being reported as better tolerated.


Real-World Evidence

Retrospective studies collecting information from consumers reported high rates of symptom improvement. One study noted that over 90% of respondents reported an improvement in symptoms and quality of life after starting treatment. Furthermore, 76%–88% of respondents perceived symptomatic relief within one day of using the product.

Frequently Asked Questions (FAQ)

Common questions about Camisten (FAQ)

Q: How quickly does Camisten usually start working?

A: Official information indicates that many people using Camisten in real-world settings have reported noticing an improvement in their symptoms within one day of starting the treatment course.

Q: Are there any long-term side effects associated with Camisten use?

A: Official information indicates that for topical use, the treatment is typically intended for short courses. Long-term studies to determine the potential for serious effects, such as cancer (carcinogenic potential), have not been performed for the active ingredient. Concerns about prolonged use should be discussed with a healthcare provider.

Q: Can children be treated with Camisten?

A: Regulatory documents state that use in children under 12 years requires direction from a doctor. For the common topical forms, it is generally not recommended for use in children under 2 years of age unless a doctor advises it. Eligibility depends on the child's age and the specific formulation used.

Q: Is Camisten safe for older adults (seniors)?

A: Safety and effectiveness in patients aged 65 and older have not been fully established for all prescription forms. Caution is generally advised when prescribing any medicine to older adults, and assessment by a healthcare professional is important to determine its appropriateness.

Q: Why does Camisten work for [Condition Camisten Treats]?

A: Camisten works by selectively disrupting the life cycle of the fungal cells. The drug blocks the synthesis of ergosterol, which is a vital structural component of the fungal cell membrane. This blockade causes the cell membrane to break down, leading to the destruction of the fungal cell.

Q: Can taking Camisten affect the results of lab tests?

A: Regulatory documents indicate that if Camisten is used at the same time as certain other drugs, it may affect lab results. For example, if used at the same time as certain other drugs, such as oral anticoagulants (blood thinners) like warfarin, close monitoring of specific lab tests, like Prothrombin Time (PT) and INR, may be necessary.

Q: Is Camisten considered a maintenance drug?

A: Camisten is primarily indicated for the local treatment of acute infections using short, defined courses (such as 3, 7, or 14 days). Regulatory labels do not classify the drug as one intended for long-term or indefinite maintenance use.

Q: What are the potential signs of a serious side effect from Camisten?

A: The official product information specifies that signs of a severe allergic or anaphylactic reaction are considered serious and warrant immediate medical evaluation. These symptoms can include a rash, hives, swelling of the face or throat, severe dizziness, or trouble breathing.

Q: Is Camisten used for more than one condition?

A: Yes, the active ingredient in Camisten (miconazole nitrate) is a broad-spectrum antifungal. It is used to treat various fungal infections, including common conditions like vulvovaginal candidiasis (vaginal yeast infection), athlete's foot, jock itch, and ringworm.

Q: Is it normal to feel tired after starting Camisten?

A: Official adverse reaction data lists fatigue as a Common side effect. This means it is an expected and frequently reported reaction, potentially affecting up to 10 out of every 100 users.

Q: Can Camisten affect my blood pressure?

A: The regulatory adverse reaction profile lists palpitations (a fast or pounding heartbeat) as an Uncommon side effect. However, there is no specific warning or statement in the official labeling about the drug directly causing changes in blood pressure.

Q: Can Camisten make you dizzy or affect driving?

A: Dizziness is listed as a Common side effect in the official product information. Dizziness is a reported side effect, and regulatory information notes that if this occurs, care should be taken when driving or operating machinery.

Q: How is Camisten eliminated from the body?

A: When Camisten is applied topically or vaginally, only small amounts of the drug are absorbed into the body. These small absorbed amounts are primarily eliminated from the body through natural processes and excreted in the urine and feces.

Q: Is there a risk of allergic reaction to Camisten?

A: Yes, there is a risk of a hypersensitivity or allergic reaction to the active ingredient or the inactive ingredients. Experiencing an allergic reaction is a strict contraindication (reason not to use) for this medicine.

Q: Why do some people experience stomach upset with Camisten?

A: Official reports indicate that nausea is a Very Common side effect, and general stomach upset is known to occur. While the specific cause of the discomfort is not detailed in patient labels, it is a recognized and frequently reported reaction.

Q: What should I watch out for when taking Camisten for the first time?

A: Key warnings include monitoring for symptoms of an allergic reaction, and stopping use if irritation or sensitization occurs. Regulatory documents advise that use should be stopped, and a healthcare provider consulted, if the infection is not improving or if any new irritation or sensitization occurs.

Q: What should I do if a minor side effect of Camisten persists?

A: Official regulatory documents advise that if a minor side effect, such as irritation, persists beyond the typical duration (e.g., 3 days) or lasts for the full treatment course, stopping use and consulting with a healthcare provider is recommended.

How should Camisten be stored and disposed of?

Official Storage and Disposal Requirements

Camisten (Miconazole Nitrate) must be stored at Controlled Room Temperature, typically between 15 to 30 C (59 to 86 F) and generally not above 25 C. The medication must be protected from excess heat and moisture, meaning it should not be stored in a bathroom, and it must not be frozen.

Regulatory labeling requires the product to be kept in its original container and tightly closed. For safety, Camisten must be kept strictly out of the sight and reach of children and pets in a secure, up-and-away location.

Disposal must adhere to local requirements for pharmaceutical waste, and all unused or expired product must be thrown away. It is specifically prohibited to flush disposable applicators or allow the product to enter drains or wastewater due to environmental precautions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Camisten found in:

A-Z Index: